CURE

FDA Grants Designation to Immunotherapy KB707 for Advanced NSCLC

The U.S. FDA has granted Regenerative Medicine Advanced Therapy designation to KB707 for the treatment of advanced/metastatic ...

FDA clears Median Technologies’ lung nodule evaluation software

The US Food and Drug Administration (FDA) has cleared a lung cancer detection tool on Median Technologies’ eyonis, a suite of artificial intelligence (AI)-based software for early cancer diagnosis.

Ultra-Processed Foods, GLP-1s, and Blood Tests: The Super Bowl Ads Go All in on Health and Longevity

IF YOU WATCHED the Super Bowl last night, you were in for a treat. The Seattle Seahawks dominated Super Bowl LX with an ...

AI-Powered Surgery Tool Repeatedly Injuring Patients, Lawsuits Claim

"The product was arguably safer before integrating changes in the software to incorporate artificial intelligence." ...
Morning Overview on MSN

Maryland quantum computer could cure cancer and steal your passwords

In a low-slung Maryland lab, scientists are racing to build a machine that could help turn cancer into a manageable disease while simultaneously threatening the cryptography that shields everything ...

AI-powered apps and bots are moving into medicine. Doctors have questions

Doctors warn AI chatbots and medical apps can spread misinformation, fuel anxiety, and delay care as patients increasingly rely on artificial intelligence for health advice.

AB Science announced that the Food and Drug Administration (FDA) granted the status of Minor Use in Major Species (MUMS) for Masivet in the treatment of canine mast cell tumors

PRESS RELEASE AB SCIENCE ANNOUNCES THAT THE FDA HAS GRANTED THE STATUS OF MINOR USE IN MAJOR SPECIES DESIGNATION FOR MASIVET IN THE TREATMENT OF CANINE MAST CELL TUMORS AB SCIENCE PRESENTS PERSPECTIVE ...